Neonatal tetanus is a life-threatening, vaccine-preventable form of generalized tetanus occurring within the first 28 days of life, caused by Clostridium tetani infection of the umbilical stump. It carries a case fatality rate of 80–100% in resource-poor settings without ICU access, and even with treatment, mortality remains approximately 50%. [1-4]
1. History
- Onset of symptoms: Typically day 5–7 of life (range 3–24 days); the incubation period equals the neonate's age at symptom onset [2]
- Feeding difficulty: The hallmark initial complaint — the infant was feeding normally and then abruptly stopped sucking or latching [2][5]
- Stiffening episodes: Generalized body stiffening or spasms triggered by touch, sound, or light [5-6]
- Umbilical cord care: Ask specifically about delivery setting (home vs. facility), instrument used to cut the cord, and any substances applied to the stump (e.g., animal dung, ash, herbal preparations) [2][5]
- Maternal immunization: Number of tetanus toxoid doses received during pregnancy or lifetime; documentation status [2][5]
- Birth attendant: Skilled vs. traditional birth attendant; sterility of delivery conditions [5]
2. Alarm Features
- Trismus (inability to open mouth/suck) in a previously feeding neonate — pathognomonic [2][5]
- Opisthotonus — severe arching of the back from extensor spasm [2]
- Apneic episodes or cyanosis — indicates laryngeal spasm or respiratory muscle involvement; immediate airway threat [7]
- Autonomic instability: Tachycardia, labile blood pressure, fever — suggests severe disease with sympathetic hyperactivity [6-7]
- Rapid progression from onset to generalized spasms (short period of onset) — correlates with worse prognosis [2]
- Low birthweight (<2.5 kg) combined with onset <6 days of life — OR 6.8 for mortality [2]
3. Medications
- Antitoxin: Human tetanus immunoglobulin (hTIG) 500 IU IM (or 250 IU in some neonatal protocols); equine antitoxin if hTIG unavailable. A trial in neonates showed mortality of 71.5% with low-dose hTIG vs. 81.8% without antitoxin [1][5][8]
- Antibiotics: Metronidazole IV is preferred (kills vegetative C. tetani); penicillin is an alternative but theoretically may worsen spasms via GABA antagonism [5][9]
- Benzodiazepines: Diazepam IV is first-line for spasm control in neonates; titrate to effect. A Cochrane review found diazepam superior to phenobarbital or chlorpromazine for neonatal tetanus mortality [8]
- Magnesium sulfate: For autonomic dysfunction; used as continuous infusion with close monitoring [5-6]
- Phenobarbital/chlorpromazine: Adjunctive sedation in resource-limited settings [6]
- Neuromuscular blocking agents (e.g., vecuronium): Reserved for refractory spasms requiring mechanical ventilation [9]
- Contraindicated: Avoid excessive stimulation during medication administration; avoid aminoglycosides (may worsen neuromuscular blockade)
4. Diet
- NPO initially if spasms are severe or airway is compromised
- Enteral feeding via soft, small-bore nasogastric tube once stabilized; parenteral nutrition if enteral feeding is not tolerated [5]
- Expressed breast milk is preferred when enteral feeding is possible
- Caloric needs are high due to sustained muscle spasms and catabolic state [7]
- Hydration: Aggressive IV fluid management; monitor electrolytes closely given risk of SIADH and autonomic instability
5. Review of Systems
- Neurologic: Muscle tone, spasm frequency/triggers, consciousness level (should be preserved in tetanus — altered sensorium suggests alternative diagnosis) [7]
- Respiratory: Apnea, cyanosis, chest wall rigidity, stridor (laryngeal spasm)
- GI: Feeding ability, abdominal rigidity, bowel sounds
- Cardiovascular: Heart rate variability, blood pressure lability
- Infectious: Fever, umbilical discharge, signs of omphalitis or sepsis (sepsis frequently coexists) [7]
- Metabolic: Rule out hypoglycemia and hypocalcemia as spasm mimics [2][7]
6. Collateral History and Family History
- Maternal vaccination records — most critical piece of collateral; ≥2 doses of TTCV with at least one during pregnancy provides 94% protection against neonatal tetanus mortality [5]
- Delivery circumstances: Home delivery, traditional birth attendant, cord-cutting instrument, cord dressing practices [2][5]
- Maternal HIV status: HIV infection reduces transplacental transfer of tetanus antibodies by ~52% [2]
- Maternal malaria: Active placental malaria reduces antibody transfer by ~48% [2]
- Siblings: History of neonatal tetanus in prior children suggests persistent risk factors
- Geographic/social context: Rural residence, conflict zones, limited healthcare access [5]
7. Risk Factors
- Incomplete or absent maternal tetanus immunization — the single most important risk factor [3][5]
- Unclean delivery practices: Home birth without skilled attendant, unsterile cord cutting [2][4]
- Application of contaminated substances to the umbilical stump (animal dung, ash, herbal pastes) [2]
- Low birthweight (<2.5 kg) [2]
- Prematurity
- Low socioeconomic status, rural residence, limited antenatal care [5][10]
- Maternal HIV or malaria (impaired antibody transfer) [2]
- Geographic: Southern Asia, Southeast Asia, sub-Saharan Africa — 12 countries have not yet achieved MNT elimination [5]
8. Differential Diagnosis
- Neonatal seizures (hypoxic-ischemic encephalopathy, metabolic) — distinguished by altered consciousness, EEG abnormalities; tetanus preserves consciousness [2][7][11]
- Hypocalcemic tetany — check serum calcium; no trismus, responds to calcium replacement [1][7]
- Hypoglycemia — check point-of-care glucose; seizures resolve with dextrose [2]
- Neonatal meningitis/encephalitis — fever, bulging fontanelle, altered sensorium, abnormal CSF [2][7]
- Birth asphyxia — history of perinatal distress, low Apgar scores, altered consciousness [2]
- Neonatal sepsis — may coexist with tetanus; look for systemic inflammatory signs [7]
- Strychnine poisoning — virtually indistinguishable clinically; absence of tonic contraction between spasms is a distinguishing feature [1]
- Drug withdrawal (neonatal abstinence syndrome) — maternal drug history
9. Past Medical History
- Birth history: Gestational age, birthweight, Apgar scores, delivery complications
- Cord care practices since birth
- Prior hospitalizations or NICU admissions
- Immunization status of the neonate (typically none at this age)
- Maternal obstetric history: Prior pregnancies, prior neonatal deaths (may suggest recurrent risk)
10. Physical Exam
- Vital signs: Fever, tachycardia, blood pressure lability (autonomic dysfunction) [6-7]
- Trismus: Inability to open the mouth; the spatula test (touching the posterior pharynx with a tongue depressor provokes jaw spasm rather than gag reflex) is highly sensitive and specific [7]
- Risus sardonicus: Sustained facial muscle spasm producing a characteristic "sardonic grin" [2]
- Generalized rigidity: Board-like abdominal rigidity, clenched fists, dorsiflexed feet [2]
- Opisthotonus: Arching of the back from extensor spasm [2]
- Stimulus-provoked spasms: Spasms triggered by touch, noise, or light [2][5]
- Umbilicus: Inspect for signs of infection — erythema, discharge, necrotic tissue [2]
- Respiratory: Chest wall rigidity, stridor, apneic episodes, oxygen saturation [7]
- Consciousness: Should be preserved — altered mental status argues against tetanus [1][7]
11. Lab Studies
- CBC: Leukocytosis may indicate concurrent sepsis [5]
- Electrolytes: Rule out hypocalcemia, hyponatremia, hypomagnesemia [2][5]
- Glucose: Rule out hypoglycemia as a seizure mimic [2]
- Creatine kinase (CK): Elevated from sustained muscle spasms [5]
- Blood cultures: To evaluate for concurrent neonatal sepsis [7]
- CRP/procalcitonin: Inflammatory markers for sepsis evaluation [5]
- BUN/creatinine: Renal function monitoring (rhabdomyolysis risk from sustained spasms)
- Serum tetanus antibody level: A level >0.1 IU/mL (pre-antitoxin) makes tetanus less likely but does not exclude it; cases have occurred above this threshold [2][5][7]
- Lumbar puncture: If meningitis is suspected; CSF is normal in tetanus [2][5]
- Wound culture: C. tetani can be cultured on anaerobic media but is frequently negative and should not delay treatment [2][7]
12. Imaging
- Chest X-ray: Evaluate for aspiration pneumonia, atelectasis from chest wall rigidity
- Head ultrasound: If birth asphyxia or intracranial hemorrhage is in the differential
- No specific imaging is diagnostic for tetanus — diagnosis is clinical [2][9]
- Imaging is primarily used to rule out alternative diagnoses and identify complications
13. Special Tests
- Spatula test: Touch the posterior pharyngeal wall with a soft spatula — a positive test (jaw spasm/biting the spatula) rather than a gag reflex is highly suggestive of tetanus (reported sensitivity 94%, specificity 100%) [7]
- Ablett classification: Severity grading system for tetanus (Grade I–IV) used for prognostication and guiding ICU management [1]
- EEG: Normal in tetanus (helps distinguish from seizure disorders); obtain if diagnostic uncertainty exists [11]
- PCR for tetanus toxin gene: Available in some reference labs; can be performed on wound exudate but rarely accessible in high-burden settings [2]
14. ECG
- Indications: All neonates with suspected tetanus should have continuous cardiac monitoring
- Findings in autonomic dysfunction: Sinus tachycardia, bradycardia, labile heart rate, arrhythmias [7]
- Dangerous patterns: Sudden bradycardia or asystole from vagal surges; ventricular arrhythmias from catecholamine excess [7]
- ST changes may occur secondary to catecholamine-mediated myocardial injury
15. Assessment
Neonatal tetanus is a clinical diagnosis made in a neonate (≤28 days old) who was initially able to feed and cry normally, then develops inability to suck (trismus), generalized rigidity, and stimulus-provoked spasms. [2][5] The disease carries a poor prognosis, with case fatality rates of 50–100% depending on resource availability. [3][5] Key prognostic factors include birthweight, age at onset, and access to ICU care. [2]
- Severity stratification (Ablett):
- Grade I: Mild trismus, no spasms, no respiratory compromise
- Grade II: Moderate trismus, short spasms, mild tachypnea
- Grade III: Severe trismus, prolonged spasms, apneic episodes, tachycardia
- Grade IV: Grade III features plus autonomic instability (labile BP, tachycardia/bradycardia) [1]
- Complications: Laryngeal spasm and respiratory arrest, aspiration pneumonia, nosocomial infections, rhabdomyolysis, fractures from spasms, prolonged immobility sequelae, and long-term neurodevelopmental impairment (cerebral palsy, cognitive delay, deafness in 20–40% of survivors) [1-2][7]
16. Treatment Plan
Initial stabilization (ED/resuscitation):
- Airway: Ensure ventilation; prepare for intubation (laryngeal spasm risk). Low threshold for early intubation in severe disease [5][9]
- Minimize stimulation: Place in a quiet, darkened room; minimize handling [5][9]
- Benzodiazepines: Diazepam 0.1–0.3 mg/kg IV, titrated to control spasms [5][8]
Definitive treatment:
- Human tetanus immunoglobulin (hTIG): 500 IU IM (some protocols use 250 IU for neonates); administer as early as possible. If unavailable, use equine antitoxin after test dose [1][5][8]
- Antibiotics: Metronidazole 7.5 mg/kg IV q8h (neonatal dosing) for 7–10 days [5][9]
- Umbilical cord care: Thorough wound debridement and cleaning of the umbilical stump [2][9]
- Tetanus vaccination: Initiate primary DTP series (tetanus does not confer natural immunity) [1]
ICU management:
- Spasm control: Continuous diazepam infusion or intermittent dosing; add phenobarbital or chlorpromazine if needed [6][8]
- Neuromuscular blockade + mechanical ventilation: For refractory spasms [9]
- Autonomic dysfunction: Magnesium sulfate infusion (loading 40 mg/kg IV over 30 min, then 20–40 mg/kg/h titrated); monitor for respiratory depression and hypotension [5-6]
- Nutrition: Nasogastric feeding with expressed breast milk; parenteral nutrition if enteral not tolerated [5]
- Supportive care: Temperature regulation, DVT prophylaxis considerations, skin care, physical therapy when spasms resolve [5]
17. Disposition
- All suspected neonatal tetanus cases require ICU admission — no exceptions [1][5][9]
- Mechanical ventilation may be needed for weeks (median ~23 days in severe cases) [2]
- Discharge criteria: Resolution of spasms, stable respiratory function off ventilator, tolerating enteral feeds, completion of initial immunization doses [5]
- Specialist consultation: Neonatology/PICU, pediatric infectious disease, pediatric neurology if diagnostic uncertainty exists
- Public health notification: Neonatal tetanus is a reportable disease; each case triggers investigation of maternal immunization status and delivery practices [3-4]
18. Follow Up / Return Precautions
- Complete the DTP vaccination series per schedule (tetanus does not confer immunity; full immunization is mandatory after recovery) [1]
- Neurodevelopmental follow-up: 20–40% of survivors have evidence of brain damage including microcephaly, cerebral palsy, cognitive delay, and deafness — early developmental screening is essential [2][7]
- Maternal immunization: Ensure the mother receives a full TTCV series to protect future pregnancies [2][5]
- Counsel on clean delivery practices and skilled birth attendance for future pregnancies [5]
- Expected recovery: Tetanus takes 6–8 weeks to fully resolve; residual rigidity may persist at discharge [2]
- Return immediately for: Recurrence of stiffness or spasms, feeding difficulty, apnea, fever, or signs of secondary infection
References
1. Tetanus: Recognition and Management. — Sudarshan R, Sayo AR, Renner DR, et al. The Lancet. Infectious Diseases. 2025.
2. Tetanus: Recognition and Management. — Sudarshan R, Sayo AR, Renner DR, et al. The Lancet. Infectious Diseases. 2025.
3. Tetanus: Recognition and Management. — Sudarshan R, Sayo AR, Renner DR, et al. The Lancet. Infectious Diseases. 2025.
4. Maternal and Neonatal Tetanus. — Thwaites CL, Beeching NJ, Newton CR. Lancet. 2015.
5. Maternal and Neonatal Tetanus. — Thwaites CL, Beeching NJ, Newton CR. Lancet. 2015.
6. Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination - Worldwide, 2000-2020. — Kanu FA, Yusuf N, Kassogue M, Ahmed B, Tohme RA. MMWR. Morbidity and Mortality Weekly Report. 2022.
7. Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination - Worldwide, 2000-2020. — Kanu FA, Yusuf N, Kassogue M, Ahmed B, Tohme RA. MMWR. Morbidity and Mortality Weekly Report. 2022.
8. Progress Toward Maternal and Neonatal Tetanus Elimination - Worldwide, 2000-2018. — Njuguna HN, Yusuf N, Raza AA, Ahmed B, Tohme RA. MMWR. Morbidity and Mortality Weekly Report. 2020.
9. Progress Toward Maternal and Neonatal Tetanus Elimination - Worldwide, 2000-2018. — Njuguna HN, Yusuf N, Raza AA, Ahmed B, Tohme RA. MMWR. Morbidity and Mortality Weekly Report. 2020.
10. Tetanus. — Ergönül Ö, Kolsuz S, Figueroa JP. Lancet. 2026.
11. Tetanus. — Ergönül Ö, Kolsuz S, Figueroa JP. Lancet. 2026.
12. Successful Management of Neonatal Tetanus With Autonomic Manifestations at a Referral Hospital in Nigeria: A Case Report. — Onyeje CK, Onyeje BT. BMC Pediatrics. 2025.
13. Successful Management of Neonatal Tetanus With Autonomic Manifestations at a Referral Hospital in Nigeria: A Case Report. — Onyeje CK, Onyeje BT. BMC Pediatrics. 2025.
14. Maternal and Neonatal Tetanus. — Roper MH, Vandelaer JH, Gasse FL. Lancet. 2007.
15. Maternal and Neonatal Tetanus. — Roper MH, Vandelaer JH, Gasse FL. Lancet. 2007.
16. Tetanus. — Yen LM, Thwaites CL. Lancet. 2019.
17. Tetanus. — Yen LM, Thwaites CL. Lancet. 2019.
18. What Is Tetanus?. — Zhou S, Malani P. The Journal of the American Medical Association. 2026.
19. What Is Tetanus?. — Zhou S, Malani P. The Journal of the American Medical Association. 2026.
20. Tetanus Toxoid Vaccination Coverage and Associated Factors among Childbearing Women in Ethiopia: A Systematic Review and Meta‐Analysis. — Nigussie J, Girma B, Molla A, Mareg M. BioMed Research International. 2021.
21. Tetanus Toxoid Vaccination Coverage and Associated Factors among Childbearing Women in Ethiopia: A Systematic Review and Meta‐Analysis. — Nigussie J, Girma B, Molla A, Mareg M. BioMed Research International. 2021.
22. Neonatal Seizures. — Yozawitz E. The New England Journal of Medicine. 2023.
23. Neonatal Seizures. — Yozawitz E. The New England Journal of Medicine. 2023.